Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 1111-1120 of 1761 for

Edit search filters
  1. A Study To Evaluate Tazemetostat And Pembrolizumab To Treat Advanced Urothelial Carcinoma

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  2. A Study Of TAK-981 In Combination With Rituximab In Participants With Relapsed/Refractory (R/r) CD20-positive (CD20+) Non-Hodgkin Lymphoma (NHL)

    Rochester, MN

  3. Study Of Retinfanlimab In Combination With INCAGN02385 And INCAGN02390 As First-Line Treatment In Participants With PD-L1-Positive (CPS ≥ 1) Recurrent/Metastatic Squamous Cell Carcinoma Of The Head And Neck

    Jacksonville, FL

  4. A Study To Evaluate Stereotactic Radiosurgery Versus Hippocampal-Avoidant Whole Brain Radiotherapy For 10 Or Fewer Brain Metastases From Small Cell Lung Cancer

    Scottsdale/Phoenix, AZ

  5. A Study To Compare Mobile Health And Social Media Physical Activity Intervention Among Adolescent And Young Adult Childhood Cancer Survivors

    Rochester, MN

  6. A Safety And Efficacy Study Of Intravenous (IV) Elezanumab Assessing Change In Neurologic Function In Adult Participants With Acute Ischemic Stroke (EAISE)

    Scottsdale/Phoenix, AZ, Jacksonville, FL

  7. Consent Forms In Cancer Research: Examining The Effect Of Length On Readability

    Rochester, MN

  8. An Open-label Study Using ASP-1929 Photoimmunotherapy In Combination With Anti-PD1 Therapy In EGFR Expressing Advanced Solid Tumors

    Rochester, MN

  9. Study Of Pembrolizumab (MK-3475) In Participants With Advanced Solid Tumors (MK-3475-158/KEYNOTE-158)

    Rochester, MN

  10. A Study To Evaluate EAA181 To Treat Newly-diagnosed Multiple Myeloma

    La Crosse, WI, Rochester, MN

.

Mayo Clinic Footer